Ginkgo Bioworks Holdings Stock Market Value
| DNA Stock | USD 8.32 0.05 0.60% |
| Symbol | Ginkgo |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. Projected growth potential of Ginkgo fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ginkgo Bioworks assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (5.81) | Revenue Per Share | Quarterly Revenue Growth (0.56) | Return On Assets | Return On Equity |
Understanding Ginkgo Bioworks Holdings requires distinguishing between market price and book value, where the latter reflects Ginkgo's accounting equity. The concept of intrinsic value - what Ginkgo Bioworks' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ginkgo Bioworks' price substantially above or below its fundamental value.
It's important to distinguish between Ginkgo Bioworks' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ginkgo Bioworks should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Ginkgo Bioworks' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Ginkgo Bioworks 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ginkgo Bioworks' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ginkgo Bioworks.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Ginkgo Bioworks on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Ginkgo Bioworks Holdings or generate 0.0% return on investment in Ginkgo Bioworks over 90 days. Ginkgo Bioworks is related to or competes with Iovance Biotherapeutics, Replimune, MBX Biosciences, MeiraGTx Holdings, ArriVent BioPharma, Maravai Lifesciences, and Vir Biotechnology. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming More
Ginkgo Bioworks Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ginkgo Bioworks' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ginkgo Bioworks Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 20.8 | |||
| Value At Risk | (6.79) | |||
| Potential Upside | 5.39 |
Ginkgo Bioworks Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ginkgo Bioworks' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ginkgo Bioworks' standard deviation. In reality, there are many statistical measures that can use Ginkgo Bioworks historical prices to predict the future Ginkgo Bioworks' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.27) |
Ginkgo Bioworks February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 3.32 | |||
| Coefficient Of Variation | (819.30) | |||
| Standard Deviation | 4.61 | |||
| Variance | 21.27 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 20.8 | |||
| Value At Risk | (6.79) | |||
| Potential Upside | 5.39 | |||
| Skewness | (1.12) | |||
| Kurtosis | 4.74 |
Ginkgo Bioworks Holdings Backtested Returns
Ginkgo Bioworks Holdings holds Efficiency (Sharpe) Ratio of close to zero, which attests that the entity had a close to zero % return per unit of risk over the last 3 months. Ginkgo Bioworks Holdings exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ginkgo Bioworks' Market Risk Adjusted Performance of (0.26), risk adjusted performance of (0.08), and Standard Deviation of 4.61 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.13, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ginkgo Bioworks will likely underperform. At this point, Ginkgo Bioworks Holdings has a negative expected return of -0.0154%. Please make sure to check out Ginkgo Bioworks' skewness, and the relationship between the treynor ratio and daily balance of power , to decide if Ginkgo Bioworks Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.70 |
Good predictability
Ginkgo Bioworks Holdings has good predictability. Overlapping area represents the amount of predictability between Ginkgo Bioworks time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ginkgo Bioworks Holdings price movement. The serial correlation of 0.7 indicates that around 70.0% of current Ginkgo Bioworks price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.7 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:Check out Ginkgo Bioworks Correlation, Ginkgo Bioworks Volatility and Ginkgo Bioworks Performance module to complement your research on Ginkgo Bioworks. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Ginkgo Bioworks technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.